| [1] |
Nkomo VT, Gardin JM, Skelton TN, et al. Burden of valvular heart diseases: a population-based study[J]. Lancet, 2006,368(9540):1005-1011.
|
| [2] |
de Marchena E, Badiye A, Robalino G, et al. Respective prevalence of the different carpentier classes of mitral regurgitation: a stepping stone for future therapeutic research and development[J]. J Card Surg, 2011,26(4):385-392.
|
| [3] |
Goel SS, Bajaj N, Aggarwal B, et al. Prevalence and outcomes of unoperated patients with severe symptomatic mitral regurgitation and heart failure: comprehensive analysis to determine the potential role of MitraClip for this unmet need[J]. J Am Coll Cardiol, 2014,63(2):185-186.
|
| [4] |
Timek TA, Dagum P, Lai DT, et al. Pathogenesis of mitral regurgitation in tachycardia-induced cardiomyopathy[J]. Circulation, 2001,104(12 Suppl 1):I47-53.
|
| [5] |
Palacios IF, Condado JA, Brandi S, et al. Safety and feasibility of acute percutaneous septal sinus shortening: first-in-human experience[J]. Catheter Cardiovasc Interv, 2007,69(4):513-518.
|
| [6] |
Worthley S, Redwood S, Hildick-Smith D, et al. Transcatheter reshaping of the mitral annulus in patients with functional mitral regurgitation: one-year outcomes of the MAVERIC trial[J]. EuroIntervention, 2021,16(13):1106-1113.
|
| [7] |
Mack MJ, Lindenfeld J, Abraham WT, et al. 3-Year Outcomes of Transcatheter Mitral Valve Repair in Patients With Heart Failure[J]. J Am Coll Cardiol, 2021,77(8):1029-1040.
|
| [8] |
Asgar AW, Mack MJ, Stone GW. Secondary mitral regurgitation in heart failure: pathophysiology, prognosis, and therapeutic considerations[J]. J Am Coll Cardiol, 2015,65(12):1231-1248.
|
| [9] |
Levine RA, Hagége AA, Judge DP, et al. Mitral valve disease--morphology and mechanisms[J]. Nat Rev Cardiol, 2015,12(12):689-710.
|
| [10] |
Dziadzko V, Clavel MA, Dziadzko M, et al. Outcome and undertreatment of mitral regurgitation: a community cohort study[J]. Lancet, 2018,391(10124):960-969.
|
| [11] |
Robbins JD, Maniar PB, Cotts W, et al. Prevalence and severity of mitral regurgitation in chronic systolic heart failure[J]. Am J Cardiol, 2003,91(3):360-362.
|
| [12] |
Gertz ZM, Raina A, Saghy L, et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control[J]. J Am Coll Cardiol, 2011,58(14):1474-1481.
|
| [13] |
Coats A, Anker SD, Baumbach A, et al. The management of secondary mitral regurgitation in patients with heart failure: a joint position statement from the Heart Failure Association (HFA), European Association of Cardiovascular Imaging (EACVI), European Heart Rhythm Association (EHRA), and European Association of Percutaneous Cardiovascular Interventions (EAPCI) of the ESC[J]. Eur Heart J, 2021,42(13):1254-1269.
|
| [14] |
Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease[J]. Eur Heart J, 2022,43(7):561-632.
|
| [15] |
Daubert C, Gold MR, Abraham WT, et al. Prevention of disease progression by cardiac resynchronization therapy in patients with asymptomatic or mildly symptomatic left ventricular dysfunction: insights from the European cohort of the REVERSE (Resynchronization Reverses Remodeling in Systolic Left Ventricular Dysfunction) trial[J]. J Am Coll Cardiol, 2009,54(20):1837-1846.
|
| [16] |
Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, et al. Quantitative determinants of the outcome of asymptomatic mitral regurgitation[J]. N Engl J Med, 2005,352(9):875-883.
|
| [17] |
Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter Mitral-Valve Repair in Patients with Heart Failure[J]. N Engl J Med, 2018,379(24):2307-2318.
|
| [18] |
Puls M, Lubos E, Boekstegers P, et al. One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry[J]. Eur Heart J, 2016,37(8):703-712.
|
| [19] |
Rogers JH, Macoviak JA, Rahdert DA, et al. Percutaneous septal sinus shortening: a novel procedure for the treatment of functional mitral regurgitation[J]. Circulation, 2006,113(19):2329-2334.
|
| [20] |
Tibayan FA, Rodriguez F, Langer F, et al. Does septal-lateral annular cinching work for chronic ischemic mitral regurgitation?[J]. J Thorac Cardiovasc Surg, 2004,127(3):654-663.
|
| [21] |
Rogers JH, Thomas M, Morice MC, et al. Treatment of Heart Failure With Associated Functional Mitral Regurgitation Using the ARTO System: Initial Results of the First-in-Human MAVERIC Trial (Mitral Valve Repair Clinical Trial)[J]. JACC Cardiovasc Interv, 2015,8(8):1095-1104.
|
| [22] |
Patterson T, Gregson J, Erglis A, et al. Two-year outcomes from the MitrAl ValvE RepaIr Clinical (MAVERIC) trial: a novel percutaneous treatment of functional mitral regurgitation[J]. Eur J Heart Fail, 2021,23(10):1775-1783.
|
| [23] |
Ren KD, Pu ZX, Yu L, et al. The first two cases of transcatheter mitral valve repair with ARTO system in Asia[J]. World J Emerg Med, 2020,11(1):33-36.
|